0001104659-24-070420.txt : 20240611 0001104659-24-070420.hdr.sgml : 20240611 20240611163048 ACCESSION NUMBER: 0001104659-24-070420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waddill William D. CENTRAL INDEX KEY: 0001553338 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 241036228 MAIL ADDRESS: STREET 1: C/O CALITHERA BIOSCIENCES STREET 2: 343 OYSTER POINT BLVD, SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm2416932-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-07 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001553338 Waddill William D. C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 1 0 0 0 1 Common Stock 2024-06-07 4 M 0 8000 12.88 A 20000 D Common Stock 2024-06-07 4 S 0 8000 35.00 D 12000 D Stock Option (right to buy) 12.88 2024-06-07 4 M 0 8000 0.00 D 2026-09-13 Common Stock 8000 16000 D Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023. These stock options are fully vested. /s/ Matthew Gosling, Attorney-in-Fact for William D. Waddill 2024-06-11